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Baculovirus expression systemSporadic hemiplegic migraine type 2 (SHM2) and familial hemiplegic migraine type 2 (FHM2) are rare forms of
hemiplegic migraine caused by mutations in the Na+,K+-ATPase α2 gene. Today, more than 70 different
mutations have been linked to SHM2/FHM2, randomly dispersed over the gene. For many of these mutations,
functional studies have not been performed. Here, we report the functional characterization of nine SHM2/
FHM2 linked mutants that were produced in Spodoptera frugiperda (Sf)9 insect cells. We determined ouabain
binding characteristics, apparent Na+ and K+ afﬁnities, and maximum ATPase activity. Whereas membranes
containing T345A, R834Q or R879W possessed ATPase activity signiﬁcantly higher than control membranes,
P796S, M829R, R834X, del 935–940 ins Ile, R937P and D999H membranes showed signiﬁcant loss of ATPase
activity compared to wild type enzyme. Further analysis revealed that T345A and R879W showed no changes
for any of the parameters tested, whereas mutant R834Q possessed signiﬁcantly decreased Na+ and increased
K+ apparent afﬁnities as well as decreased ATPase activity and ouabain binding.We hypothesize that themajor-
ity of the mutations studied here inﬂuence interdomain interactions by affecting formation of hydrogen bond
networks or interference with the C-terminal ion pathway necessary for catalytic activity of Na+,K+-ATPase,
resulting in decreased functionality of astrocytes at the synaptic cleft expressing these mutants.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The Na+,K+-ATPase is a cation-transporting membrane protein
involved in active transport of sodium and potassium ions against
their concentration gradients across the cell membrane. For every
molecule of ATP consumed, three sodium ions are exported from the
cell in exchange for import of two potassium ions. The Na+,K+-
ATPase serves many roles, including cell-volume homeostasis as well
as maintenance of the membrane potential. In addition, the generated
Na+ and K+ gradients drive various secondary active transporters.
Since transport of Na+ and K+ across the cell membrane takes place
against such steep concentration gradients, the enzyme consumes
high amounts of energy: approximately 25–50% of cellular ATP is
consumed by the Na+,K+-ATPase [1,2].
The Na+,K+-ATPase consists of at least two different subunits: an
α-subunit (110 kDa), containing ten transmembrane α-helices
(αM1–αM10) and two large cytosolic loops (αM2–αM3 and
αM4–αM5), together with a highly glycosylated single transmembrane
domain spanning β-subunit (50 kDa). In some tissues, a third subunit31 24 36 14214.
. Weigand),
udumc.nl (F.G.M. Russel),containing a characteristic FXYD motif is present as well (γ-subunit)
[3]. In the human genome, four α-subunit encoding genes have been
described. The proteins encoded by these genes share a sequence
homology of approximately 80–90% and are expressed tissue speciﬁcal-
ly [4]. For example, the α1-isoform is expressed ubiquitously [5],
whereas the α4-isoform is detected only in the testis [6]. The
α3-isoform is present in both the central and peripheral nervous
systems [7,8], whereas the α2-isoform is expressed in different tissues
including heart skeletal muscle, vascular smooth muscle, bone,
adipocytes, and astrocytes [9].
Genetic studies have linked over 70 mutations in the ATP1A2 gene
(chromosome 1q23) encoding the α2-isoform of the Na+,K+-ATPase
to sporadic/familial hemiplegic migraine type 2 (SHM2/FHM2), shown
in Fig. 1 [10]. Sporadic (only one affected family member) and familial
(two or more affected family members) hemiplegic migraine are
autosomal-dominant monogenic subtypes of migraine with aura
(MA), characterized by neurological aura symptoms preceding the mi-
graine attack. In addition to the mutations present in the α2-isoform
of Na+,K+-ATPase, two other genes have been linked to FHM: CACNA1A
has been linked to SHM1/FHM1 whereas SCN1A has been associated
with FHM3 (no sporadic mutations reported) [11]. Together, SHM and
FHM show a prevalence of approximately 0.005% [12,13].
The exact pathophysiology of SHM2/FHM2 remains to be elucidated,
but it is assumed that α2-isoform Na+,K+-ATPase mutations result in
Fig. 1.Homologymodel of theα2-isoform of Na+,K+-ATPase (based on PDB ID: 2ZXE [38]) showing the residues that are associatedwith SHM2/FHM2mutations in literature highlighted
in green, whereas the mutations described in the present study are highlighted in yellow. The α-subunit is shown in blue, whereas red represents the β-subunit: these two subunits
together constitute a functional Na+,K+-ATPase.
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expressing the α2-isoform are present as supporting cells. The Na+,
K+-ATPase present at the plasma membrane of these cells presumably
plays a role in uptake of K+ from the synaptic cleft following nerve
excitation, resulting in a favorable driving force for the re-uptake of
glutamate by the co-localized glutamate transporter [14]. Changes in
the enzymatic properties of the Na+,K+-ATPase might therefore have
an indirect effect on signal transmission via the synaptic cleft, leading
to hemiplegic migraine attacks.Over 70 SHM2/FHM2 causing mutations in the ATP1A2 gene have
been reported, randomly dispersed over the gene [15]. For many of
these mutations the effects on enzyme functionality have not been
reported yet, whereas investigation of the biochemical effects of each
of these mutations on protein functionality is an essential step towards
understanding the pathogenesis of SHM2/FHM2 mutations. Using
Spodoptera frugiperda (Sf)9 insect cells lacking endogenous Na+,K+-
ATPase, we set out to characterize the enzymatic effects of nine
SHM2/FHM2 mutations (all except T345A) located within the
1695K.M. Weigand et al. / Biochimica et Biophysica Acta 1838 (2014) 1693–1700carboxy-terminal transmembrane segment: T345A, P796S, M829R,
R834Q, R834X (truncated protein), R879W, del 935–940 ins Ile, R937P
and D999H. The carboxy-terminal segment is present only in PII- and
PIIIa-type ATPases of the P-type ATPase family [16]. It plays a vital role
in the catalytic activity of the Na+,K+-ATPase as was illustrated by the
discovery of an essential C-terminal half-channel forming a gateway
to the third ion-binding site, allowing protons to access the third ion-
binding site as required for K+ occlusion [17]. Interestingly, various
SHM2/FHM2mutations have beenmapped to this half-channel, leading
us to investigate extensively the biochemical effects of mutations
located within this region of the Na+,K+-ATPase.
2. Methods
2.1. The Gateway system
The cDNA for the α2-isoform was obtained by purchasing a vector
(Thermo Scientiﬁc MHS1011-9199751) containing the cDNA obtained
from a human teratocarcinoma cell line (cDNA: NM_000702). The
desired mutations were obtained by performing two PCRs (A and B)
on human Na+,K+-ATPase α2 wild type cDNA using either a 5′ or a 3′
primer together with a mutagenesis primer (Biolegio, Nijmegen, The
Netherlands) containing the desired mutation (see Supplementary
Table 1). This resulted in generation of two fragments that were subse-
quently combined in a PCR (C) using only the 5′ and 3′ primers,
allowing for annealing of the two fragments. Using Gateway cloning
(Life Technologies, Breda, The Netherlands), the mutated Na+,K+-
ATPase α2 gene was then transferred to an entry vector containing a
kanamycin resistance cassette using BP Clonase II enzyme according
to the manufacturer's instructions. After successful transformation of
entry clones into Escherichia coli DH5α cells and overnight selection
on kanamycin LB-agar plates, colonies were inoculated in LB medium
containing kanamycin, grown overnight and subsequently isolated
using the GenElute™ mini-prep isolation kit (Sigma-Aldrich). Then,
full-length sequencing of the different constructs was performed to
check for successful mutagenesis. Subsequently, expression clones
were obtained by inserting the α2 gene carrying the mutation in the
Gateway Reading Frame Cassette B behind a polyhedrin promoter in
an ampicillin resistant pFastBac Dual transfer vector containing the
β1-subunit behind the p10 promoter using LR Clonase II enzyme (Life
Technologies, Breda, The Netherlands). After successful transformation
of expression clones into E. coli DH5α cells and overnight selection on
ampicillin LB-agar plates, colonies were inoculated in LB medium
containing ampicillin, grown overnight and subsequently isolated using
the GenElute™mini-prep isolation kit (Sigma-Aldrich). Throughout the
cloning procedures, YFP was used as a negative control, resulting in the
generation of an expression clone encoding YFPβ1.
2.2. Generation of recombinant baculoviruses
The expression clones generated using the Gateway system were
transformed to competent DH10Bac E. coli cells (Life Technologies,
Breda, The Netherlands) harboring the baculovirus genome (bacmid)
and a transposition helper plasmid, conferring resistance against
kanamycin, gentamycin, and tetracycline. Upon transposition between
the Tn7 sites present in both bacmid and expression clones [18], recom-
binant bacmids were selected on LB-agar plates containing kanamycin,
gentamycin, and tetracycline. Subsequently, resistance-selected bacmids
were transfected to S. frugiperda (Sf)9 insect cells grown inGracemedium
(Sigma, Bornem, Belgium) at 27 °C in 175 cm2 monolayers using
Cellfectin reagent (Life Technologies, Breda, The Netherlands). After a
6-day period, recombinant baculoviruses were harvested and used to
infect fresh Sf9 cells at a multiplicity of infection of 0.1 [19]. After another
6 days of culture of infected Sf9 cells, ampliﬁed baculoviruses were
harvested [20].2.3. Protein production using recombinant virus
Sf9 cells grown at 27 °C in 175 cm2 monolayers and later in 500 mL
shaking ﬂasks in Xpress medium (Sigma, Bornem, Belgium) were in-
fected at a density of 1.5 · 106 cells mL−1 in the presence of 1% (v/v)
ethanol as described before [21]. After three days of infection, the cells
were harvested by centrifugation at 2000 ×g for 5 min. Then, the
pelleted cells were resuspended at 0 °C in a 0.25 M sucrose, 2 mM
EDTA and 20mMHepes/Tris (pH 7.0) buffer. Sonication was performed
for 30 s at 80 W prior to centrifugation at 10,000 ×g at 4 °C for 30 min,
followed by centrifugation of the resulting supernatant at 100,000 ×g at
4 °C for 60 min. The pelleted membranes were resuspended using the
buffer mentioned above, homogenized and stored at−20 °C and the
protein concentrationwas determined using themodiﬁed Lowrymeth-
od [22].
2.4. Western blotting
Approximately 10 μg of membranes was treated with SDS-PAGE
solubilization buffer overnight at room temperature before loading on
a 10% polyacrylamide gel, as described previously [23]. After separation,
the proteinswere transferred overnight to a nitrocellulosemembrane at
30 V. The alpha and beta subunits were detected using either the
C356-M09 (α-subunit) or the C385-M77 (β-subunit) antibodies, re-
spectively [21,23].
2.5. Ouabain binding experiments
Ouabain binding was determined by incubation of approximately
150–200 μg of membranes in the presence of 20 mM histidine, 5 mM
MgCl2, 5 mM H3PO4 pH 7.0 and 25 nM of radiolabeled ouabain
(Perkin-Elmer, Waltham, MA, USA) in a ﬁnal volume of 60 μL at room
temperature for 2 h. After incubation for 15 min on ice, the amount of
bound ouabain was determined by washing the samples over a 0.8 μm
ME27 ﬁlter using distilled H2O, retaining the enzyme-bound ouabain
to the ﬁlters. The amount of radioactivity on the ﬁlters was then deter-
mined in a liquid scintillation counter after addition of 4 mL OptiFluor
(Canberra Packard, Tilburg, The Netherlands) [24]. Correction for
endogenous ouabain bindingwas performed by subtracting the amount
of ouabain bound in YFPβ1 samples.
2.6. ATPase activity studies
ATPase activity was determined in the Na+ or K+ afﬁnity studies by
incubating 20 μL of membranes in a ﬁnal volume of 100 μL containing
50 mM Tris–Ac pH 7.0, 0.1 mM EGTA, 1.2 mMMgCl2, 1.0 mM Tris–N3,
and 100 μM of radiolabeled ATP in the presence of 50 mM NaCl or
5.0 mM KCl and increasing concentrations of KCl or NaCl, respectively.
After incubation of the samples for 30 min at 37 °C, the reaction was
stopped by addition of 500 μL 10% (w/v) charcoal in 6% (v/v) trichloro-
acetic acid and, after 10min at 0 °C, themixturewas centrifuged for 30 s
(10,000 ×g). Subsequently, 150 μL of the clear supernatant was mixed
with 4 mL OptiFluor before analysis using a liquid scintillation counter
to determine the amount of formed Pi (inorganic phosphate), ameasure
of ATPase activity [25]. Na+,K+-ATPase speciﬁc activity was determined
by subtracting the amount of Pi formed in the presence of 1.0 mM
ouabain. [γ-32P]ATP (3000 Ci mmol−1) was obtained from Perkin-
Elmer (Waltham, MA, USA).
2.7. Data analysis
All data were analyzed using GraphPad Prism 5.02. Repeated
measures ANOVA was used to test for differences in apparent Na+ and
K+ afﬁnities and maximum ATPase activity levels compared with α2
wild type enzyme, with α = 0.05. Ouabain binding characteristics
(maximumouabain binding (EOmax) andKd)were tested for differences
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Na+ and K+ afﬁnities the Origin 6.1 (Microcal, Northampton, MA) soft-
ware was used to perform non-linear regression analysis. The Na0.5+ and
K0.5+ values (deﬁned as the concentrations of Na+ and K+ resulting in
half-maximal activation) were calculated via the Hill equation using
the averaged data and SEM values, and the Hill coefﬁcients (nH) obtain-
ed for wild type Na+,K+-ATPase were also used for calculation of the
mutant half-maximum Na+ and K+ concentrations. Maximum ATPase
activity was determined in the presence of 50 mM NaCl, 5.0 mM KCl,
1.2 mMMgCl2 and 0.1 mM ATP at pH 7.0.
2.8. Structural analysis
Homology models based on different crystal structures of the
α1β1 Na+,K+-ATPase (enzyme obtained from pig and shark) and
sarcoplasmatic reticulumCa2+-ATPase (SERCA)were used as templates
to investigate the possible interactions between residues of interest
using the YASARA software. The following PDB entries were used
(corresponding enzyme conformation): 2C9M (E1Na+), 1T5S (E1Na+-
ATP), 1T5T (E1Na+-P-ADP), 3BA6 (E1Na+P:ADP), 3B9B (E2P), 3B9R
(E2K+-P-ATP), 2ZXE (E2.K+.Pi), and 2C88 (E2K+ ATP). The homology
modelswere built using the YASARA software and theWHAT IF Twinset
using default parameters. YASARA-calculated Z-scores were used for
validation and selection of the best model and ranged from −1.990
(3B9R), −1.788 (3B9B), −1.762 (2C9M), −1.699 (1T5T), −1.644
(3BA6),−1.557 (2C88),−1.548 (1T5S) to−0.454 (2ZXE). Minimiza-
tion was performed using an automatic YASARA protocol and default
settings [26].
3. Results
3.1. General characterization of ATP1A2 migraine mutants
We selected 9 ATP1A2 SHM2/FHM2 causing mutations identiﬁed in
the C-terminal part of the α2-subunit of the Na+,K+-ATPase to investi-
gate the effects of these mutations on the enzyme's apparent Na+, K+,
and ouabain afﬁnities, as well asmaximumATPase activity and ouabain
binding. Baculovirus infected Sf9 insect cells were used to obtain mem-
brane fragments containing the desired mutants. Fig. 2 shows that the
amount of protein detected was equal for all mutants compared to
wild type enzyme, indicating similar expression levels. As expected,
the α-subunit could not be detected in membranes from cells infected
with YFP (neg. control).
Subsequently, we investigated protein functionality as reﬂected by
ouabain binding. Ouabain is a well-known and highly speciﬁc ligand
of Na+,K+-ATPase that binds in a pocket constituted by the ﬁrst six
transmembrane spanning domains and speciﬁc residues present in
several extracellular loops connecting these transmembrane domainsFig. 2.Western blot showing equal protein expression for all mutants tested in this study.
For eachmutant, 10 μg of Sf9membranes was incubated overnight in solubilization buffer
and used for SDS-PAGE using 10% acrylamide gels followed by transfer to a nitrocellulose
membrane and subsequent detection with antibodies against the α-subunit (C356-M09)
and β-subunit (C385-M77). Note that the lower band for mutant R834X (insertion stop
codon) reﬂects a truncated protein, as expected.[26]. Therefore, binding of ouabain implies that the ﬁrst six transmem-
brane domains of Na+,K+-ATPase are properly folded. Fig. 3 shows
the amount of ouabain binding under equilibrium after incubation
with 25 nM radiolabeled ouabain. Wild type, T345A, R879W, R834Q,
and R937P membranes showed signiﬁcantly higher ouabain binding
levels compared with control membranes expressing YFP.
Next, we tested the ATPase activity of all mutants by incubation of
membranes in the presence of 50 mM NaCl, 5.0 mM KCl, 100 μM ATP
and 1.2 mM MgCl2 for 30 min. Table 1 shows that mutants T345A,
R834Q and R879W possessed signiﬁcantly higher ATPase activity than
YFP control membranes. We observed that two mutants (R879W and
R834Q) showed decreased levels of maximumATP conversion compared
withwild type enzyme: R834Q showed a statistically signiﬁcant decrease
of 78% (P = 0.03) and mutant R879W showed a near-signiﬁcant
decrease in ATPase activity of 49%.
Based on the presence of ATPase activity as described above,we test-
ed mutants T345A, R879W and R834Q with regard to their ouabain
binding characteristics (Fig. 4, Table 2) and determined the maximum
ouabain binding (EOmax) as well as ouabain afﬁnities for the different
mutants. EOmax values ranged from 4.8 pmol/mg for wild type enzyme
to 6.3 pmol/mg for T345A, whereas mutants R879W and R834Q
showed lower maximum ouabain levels of 2.7 and 0.5 pmol/mg, the
latter being signiﬁcantly decreased when compared with wild type
enzyme. The ouabain afﬁnities were identical for wild type and T345A
(Kd = 21 ± 11 and 21 ± 6 nM), whereas R879W and R834Q showed
non-signiﬁcant increases in ouabain afﬁnities compared with wild
type enzyme (Kd = 12 ± 3 and 12 ± 4 nM).
3.2. Apparent Na+ and K+ afﬁnities and turnover numbers
6 out of the 9 mutants possessed no signiﬁcant ATPase activity
(Table 1), providing a hypothesis for their pathogenicity: loss of catalytic
activity. However, the lack of ATPase activity also excluded thesemutants
from further biochemical characterization using ATPase related studies.
As a result, we could only determine the Na+ and K+ afﬁnities for the
remaining three mutants: T345A, R834Q, and R879W (Fig. 5, Table 2).
The apparent Na+ afﬁnity was studied by investigating the amounts
of radioactive ATP hydrolyzed under increasing concentrations of NaCl
in the presence of 5.0 mM KCl, 100 μM ATP and 1.2 mM MgCl2. The
results of these experiments can be observed in Fig. 5A and Table 2.
We observed no signiﬁcant changes for mutants T345A and R879W
compared with wild type, whereas mutant R834Q showed a signiﬁ-
cant two-fold decrease in apparent Na+ afﬁnity compared with
wild type (P = 0.0007).
The apparent K+ afﬁnity was determined from the amounts of
radioactive ATP hydrolyzed under increasing KCl concentrations in the
presence of 50 mM NaCl, 100 μM ATP and 1.2 mM MgCl2. The results
of these experiments are shown in Fig. 5B and Table 2. There were no
signiﬁcant changes in apparent afﬁnities for T345A and R879W
compared with wild type enzyme, whereas mutant R834Q showed a
signiﬁcant two-fold increase in apparent K+ afﬁnity (P = 0.013). This
ﬁnding is a mirror image of the result observed for the Na+ afﬁnity of
the same mutant, which showed a two-fold decrease in afﬁnity.
By dividing the maximum ATPase activity by the maximum ouabain
binding (Table 2), we calculated the turnover number, which is a mea-
sure for the speciﬁc activity. We did not ﬁnd any statistically signiﬁcant
differences for the mutants described here (data not shown).
3.3. In silico studies based on homology models
Finally, we performed in silico mutagenesis studies using homology
models based on crystal structures of the α1β1 isoform of Na+,K+-
ATPase as well as the highly similar sarcoplasmatic reticulum Ca2+-
ATPase (SERCA). For the three mutants showing ATPase activity, no in-
teractions involving Tyr345 and Arg879 or their substitutes (alanine and
tryptophan, respectively) were predicted, however a hydrogen bond
Fig. 3. Amount of bound radiolabeled ouabain for the different mutants. Binding was determined using scintillation counting after 2 h of incubation with 25 nM ouabain at room
temperature. Compared to the negative control membranes expressing YFPβ1, wild type andmutants T345A, R834Q, R879W, and R937P showed signiﬁcantly increased levels of ouabain
binding at equilibrium (* = P b 0.05 versus neg. control).
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Glu363 in the E2.K+.Pi conformation, Asp767 in the E2P conformation, and
Asp839 in the E2K+ATP conformation (Fig. 6). Regarding the sixmutants
showing a complete loss of ATPase activity: a hydrogen bond was
predicted between serine when introduced at position 796 (P796S)
and Arg884, a residue predicted to interact with Gln907 as well. Also,
introduction of arginine at residue 829 (M829R) led to formation of
two hydrogen bonds with Val756.4. Discussion
We investigated the biochemical characteristics of nine mutations/
deletions in the α2-isoform of Na+,K+-ATPase linked to sporadic/
familial hemiplegic migraine type 2 (SHM2/FHM2) in order to increase
our knowledge on the pathogenesis of each of these mutations. All mu-
tants could be expressed in Sf9 insect cells. However, further experi-
ments revealed that six mutants could not be studied in detail due to
signiﬁcant loss of ATPase activity. Three mutants (T345A, R834Q, and
R879W) were characterized biochemically, showing signiﬁcant effects
on apparent Na+- and K+-afﬁnities for mutant R834Q. Below, we will
describe the ﬁndings for each mutant and provide hypotheses on how
each mutation might lead to the observed effects.Table 1
MaximumATPase activity for all mutants studied. Results were obtained by averaging the
amount of ATP consumed at 37 °C for 30 min in a medium consisting of 50 mM NaCl,
5.0 mM KCl and 100 μM ATP, corrected for non-speciﬁc ATPase activity by incubation of
membraneswith 1.0 mMouabain and subsequently background-corrected by subtracting
the activity observed for YFPβ1 expressing control membranes.
Max. ATPase μmol Pi mg−1 h−1
Wild type 1.05 ± 0.27
T345A 1.34 ± 0.38
P796S −0.02 ± 0.03⁎
M829R 0.00 ± 0.01⁎
R834Q 0.23 ± 0.05
R834X −0.03 ± 0.02⁎
R879W 0.54 ± 0.08
Del 935–940 ins Ile −0.05 ± 0.01⁎
R937P −0.04 ± 0.01⁎
D999H −0.02 ± 0.01⁎
⁎ P b 0.05 versus wild type.T345A was linked to FHM2 in a study describing a Finnish family of
which 10 individuals were experiencing FHM attacks, whereas two
individuals carried the mutation but most likely did not yet reach the
age of onset-of-disease [27]. We did not detect signiﬁcant changes for
any of the parameters tested, although we observed a slightly higher
maximum ATPase activity, which was accompanied by a parallel
increase in EOmax. Although we were not able to identify any interac-
tions of the highly conserved Tyr345, van der Waals' interactions with
Val362 were hypothesized before [28,29]. Previously, a decreased K+
afﬁnity and unchanged turnover number were reported for T345A rat
cDNA expressed in HeLa cells [30], whereas a study in COS-1 cells
showed a reduction in ouabain afﬁnity, an unchanged K+ afﬁnity, and
a decreased turnover number, which were linked to a reduced maxi-
mum phosphorylation rate [28]. In contrast to these studies, we used
a non-mammalian expression system with two important beneﬁts
over the two expression systems mentioned above: the absence
of background Na+,K+-ATPase as well as equimolar expression of the
α- and β-subunits. The differences between these expression systems
might provide explanations for the differences between these studies
and our results.Fig. 4. Ouabain binding characteristics of mutants T345A, R834Q, and R879W and wild
type enzyme. Membranes were incubated with different concentrations of radiolabeled
ouabain at room temperature for 2 h, followed by ﬁltration overME-27 ﬁlters. Radioactiv-
ity retained on the ﬁlters, containing the enzyme–ouabain complex, was subsequently
quantiﬁed using liquid scintillation analysis.
Table 2
Characteristics of ATPase activity and ouabain binding for wild type, T345A, R834Q and R879W enzymes. ATPase experiments using radiolabeled ATP were performed to determine ap-
parent Na+ and K+ afﬁnities and maximum ATPase values, whereas radiolabeled ouabain was used to determine apparent ouabain afﬁnity and maximum binding level.
ATPase activity Ouabain binding
Max. ATPase μmol Pi mg−1 h−1 Na0.5+ mM K0.5+ mM Max. binding pmol/mg protein Afﬁnity nM
Wild type 1.05 ± 0.3 5.9 ± 0.2 1.10 ± 0.1 4.80 ± 1.2 21.0 ± 10.4
T345A 1.34 ± 0.4 6.2 ± 0.2 1.30 ± 0.1 6.30 ± 2.1 21.0 ± 6.3
R834Q 0.23 ± 0.1⁎ 11.6 ± 0.4⁎ 0.50 ± 0.1⁎ 0.50 ± 0.0⁎ 11.8 ± 4.0
R879W 0.54 ± 0.1 6.5 ± 0.3 1.00 ± 0.0 2.70 ± 0.4 11.9 ± 3.0
nH = 2.03 nH = 1.93 nH = 1.00
nH = Hill coefﬁcient.
⁎ P b 0.05 versus wild type.
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eleven individuals suffering from FHM[31].We identiﬁed a signiﬁcantly
decreased apparent Na+ afﬁnity, increased apparent K+ afﬁnity, and
decreased maximum ATPase activity and maximum ouabain binding
compared to wild type enzyme. An increase in apparent K+ afﬁnity
has been reported before [28], but we are the ﬁrst to report a decrease
in apparent Na+ afﬁnity for this mutation. Based on the lower maxi-
mum ATPase activity, re-uptake of K+ from the synaptic cleft might be
decreased, although an increased apparent K+ afﬁnity could diminish
this effect. As predicted by the homology models used in this study,
Arg834 is involved in interactions with other residues present in the
cytosolic domains of Na+,K+-ATPase, serving an important role in inter-
actions between different domains during the catalytic cycle as pointed
out before [32]. Being located in the cytosolic loop between the sixth
and seventh transmembrane domains (αM6–αM7), Arg834 is also part
of the C-terminal half-channel, serving as a gateway to the third
ion-binding site by allowing protons to access this site as required for
K+ occlusion [17]. We hypothesize that substitution of Arg834 with a
glutamine (resulting in removal of a positive charge at this residue)
disturbs hydrogen bond interaction networks shown in Fig. 6, thereby
affecting the structure and/or accessibility of the C-terminal half-
channel, interfering indirectly with apparent Na+ and K+ afﬁnities
and the transitions between different conformations.
Mutation R879W was found in a screen for mutations in patients
suffering from sporadic hemiplegic migraine (SHM) and was identiﬁed
together with another mutation of the same non-conserved residue,
R879Q [33]. Although no mutations were detected in 92 controls, both
ATP1A2 mutations were also found in non-affected family members,
questioning the dominance in SHM. Our data seem to conﬁrm this
lack of causality, as they show a non-signiﬁcant increase in ouabain
afﬁnity as well as a non-signiﬁcant decrease in apparent maximum
ATPase activity compared to wild type enzyme. Based on analysis of
different homology models, we were not able to identify any hydrogen
bond interacting residues for Arg879, in linewith the low conservation of
this residue among different isoforms. Previously, we reported on
another mutation at the same position (R879Q), which showed only
minor changes in the enzyme's biochemical properties, leading us toFig. 5.Average (n≥ 3) background correctedNa+ (A) and K+ (B) ATPase activities for wild type
amount of radioactive ATP hydrolyzed after incubation of membranes for 30 min at 37 °C undconclude that this mutation might not be pathogenic [19]. Here, we
conclude the same for R879W, strengthening our hypothesis that
there is no link to SHM for mutations involving Arg879.
Mutation P796S was linked to FHM2 in a Portuguese family by a cell
assay that showed no survival of HeLa cells transfected with themutat-
ed Na+,K+-ATPase, inferring pathogenicity for thismutation [29]. Intro-
duction of serine resulted in prediction of a hydrogen bondwith Arg884,
which in turn is involved in a hydrogen bondwith Gln907, located in the
C-terminal half of the extracellular loop between αM7 and αM8, impli-
cated in interactions between theα- and β-subunits [34]. Possibly, sub-
stitution of proline with serine results in affected interactions between
both subunits leading to a complete loss of ATPase activity as observed
here, ormight result in improper insertion of the enzyme into themem-
brane due to loss of these interactions.
M829Rwas identiﬁed in a study describing multiple newmutations
linked to FHM2 [31] and subsequently reported to result a minor
increase in apparent K+ afﬁnity in oocytes [32]. Our study shows a
complete loss of ATPase activity for this mutant, implying an even
more severe effect of this mutation. Again, the difference in experimen-
tal results might be related to the insect cells used here, which are
cultured at 27 °C instead of 18 °C used for oocytes. Based on analysis
of the ﬁrst crystal structure of the Na+,K+-ATPase [35], the highly
conserved Met829 has been implicated in important interactions stabi-
lizing the interdomain interface region between αM6 and αM7 during
the catalytic cycle [32]. Therefore, it is likely that replacement of methi-
onine with arginine results in disturbance of these essential hydrogen
bond networks, leading to loss of ATPase activity as shown here.
The mutations R834X [36], del 935–940 ins Ile [31], R937P [31] and
D999H [37], all showing complete loss of ATPase activity, affect one or
more residues involved in the structure of the C-terminal pathway.
This half-channel controls the access of protons from the cytosol to
the third proposed ion-binding site and plugs this channel upon occlu-
sion of the third ion binding site (IIIb) by either Na+ (E1 state) or H+
(E2 state) [17]. Disruption of this half-channel could therefore easily
lead to loss of ATPase activity resulting from the absence of Na+ and
K+ occlusion, in particular for themutations affecting multiple residues
of the C-terminal segment including R834X (insertion stop codon) and, T345A, R834Q and R879Wenzymes. ATPase activities were determined bymeasuring the
er different concentrations of either NaCl (A) or KCl (B).
Fig. 6. Conformation dependent hydrogen bond interactions between Arg834 and various other amino acids that take place during the Na+,K+-ATPase reaction cycle. Arg834 is predicted to
interactwith Glu285 andGlu363 in the E2.2K+.Pi conformation (homologymodel based on 2ZXE), Asp767 in the E2P conformation (homologymodel based on 3B9B), andAsp839 in the E2K+
ATP conformation (homology model based on 2C88).
1699K.M. Weigand et al. / Biochimica et Biophysica Acta 1838 (2014) 1693–1700del 935–940 in. Ile. Arg937 was found to play a role in controlling the
C-terminal tyrosine residues essential for ATPase activity by forming
hydrogen bonds and cation–π interactions [17]. The same study also
described Asp999 as one of the residues facing inwards into the proposed
channel, highlighting the importance of this residue for ATPase activity
as well. We hypothesize that mutation of this residue into a positively
charged histidine disturbs C-terminal function, interfering with the
afﬁnity and occlusion of Na+ and/or H+, thereby indirectly affecting
ATPase function.
In conclusion, we found a statistically signiﬁcant decrease in maxi-
mumATPase activity and apparent K+ afﬁnity togetherwith an increase
in apparent Na+ afﬁnity for mutation R834Q. Mutants T345A and
R879Wdid not show any signiﬁcant changes for the parameters studied
here. Mutants P796S, M829R, R834X, del 935–940 ins Ile, R937P and
D999H could not be tested due to a lack of ATPase activity, but this
might explain how these mutations, as well as R834Q, lead to develop-
ment of SHM2/FHM2 by affecting transport of K+ and Na+ between the
synaptic cleft and supporting cells expressing the α2-isoform of Na+,
K+-ATPase. Lack of transport of Na+ and K+ is believed to affect the
secondary active transport of glutamate eventually leading to decreased
recovery from neural excitation associatedwith development of SHM2/
FHM2 attacks.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.03.022.
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